Clinical trial
Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in…
NCT00228904 · Florida Atlantic University, Other · Withdrawn
Key facts
| NCT number | NCT00228904 |
|---|---|
| Title | Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes |
| Official title | Effects of Pulsatile IV Insulin Delivery on Peripheral Diabetic Neuropathy |
| Lead sponsor | Florida Atlantic University, Other |
| Collaborators | Advanced Diabetes Treatment Centers Global Infusions Industry |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy |
| Intervention type | Procedure |
| Interventions | Placebo, Pulsatile IV insulin delivery (humalog, humulin, novolog) |
| Enrollment | 0 |
| Start date | Feb 1, 2005 |
| Primary completion | May 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Sep 29, 2005 |
| Last update posted | Aug 10, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: